You are currently browsing the archives for 22 July 2016.
Displaying 1 entry.

Funding: This work was EC EC VI Framework Programme contract number LSHG CT 2004-512003.

The authors also acknowledge the support of: the Italian Telethon Foundation , the Swiss National Science Foundation , the Max Planck Society , MRC , Association pour la Recherche sur le Cancer and Ingenio 2010 MEC Consolider CSD2007-00023, DIGESIC BFU2008 – MEC-00. CIBERSAM / ISCIII . The funders had. No role in study design, data collection and analysis, decision to publish , or preparation of the manuscript.. Funding: This work was EC EC VI Framework Programme contract number LSHG – CT – 2004-512003.

Mucormycosis has a high mortality rate even with aggressive surgical intervention. Mortality rates range from 20 to 80 percent, depending on the site involved and whether the patient any underlying immune problems. ‘This work was able to reach only possible through the close cooperation of all scientists involved and nicely illustrates the success of a coordinated and concerted effort, the gene expression atlas will be an important guide gene function and gene function and disease mechanisms says Professor Andrea Ballabio, the coordinator Telethon Telethon Institute of Genetics and medicine, Italy.. The mainstay treatment for mucormycosis is early surgical intervention all all dead an infected tissue, along with intravenous and antifungal therapy.